No abstract available
Publication types
-
Clinical Trial
-
Clinical Trial, Phase I
-
Comparative Study
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Antibodies, Neoplasm* / immunology
-
Antigens, Neoplasm / analysis*
-
Biomarkers, Tumor / analysis*
-
Breast Neoplasms / diagnostic imaging*
-
Breast Neoplasms / genetics
-
Breast Neoplasms / mortality
-
Breast Neoplasms / pathology
-
Carcinoma / diagnostic imaging*
-
Carcinoma / genetics
-
Carcinoma / pathology
-
Carcinoma, Squamous Cell / diagnostic imaging
-
Carcinoma, Squamous Cell / genetics
-
Europe
-
Female
-
Head and Neck Neoplasms / diagnostic imaging
-
Head and Neck Neoplasms / pathology
-
Humans
-
Isotope Labeling / methods
-
Lymphatic Metastasis / diagnostic imaging*
-
Mice
-
Mice, Nude
-
Neoplasm Proteins / analysis*
-
Neoplasm Proteins / genetics
-
Neoplasm Proteins / immunology
-
Neoplasm Staging / methods
-
Neoplasm Transplantation
-
Ovarian Neoplasms / diagnostic imaging
-
Ovarian Neoplasms / pathology
-
Prognosis
-
Proto-Oncogene Mas
-
Proto-Oncogene Proteins / analysis*
-
Proto-Oncogene Proteins / genetics
-
Proto-Oncogene Proteins / immunology
-
Proto-Oncogenes*
-
Radioimmunodetection*
-
Receptor, ErbB-2
-
Technetium / pharmacokinetics
-
Tissue Distribution
-
Tumor Cells, Cultured
Substances
-
Antibodies, Neoplasm
-
Antigens, Neoplasm
-
Biomarkers, Tumor
-
MAS1 protein, human
-
Neoplasm Proteins
-
Proto-Oncogene Mas
-
Proto-Oncogene Proteins
-
Technetium
-
Receptor, ErbB-2